Author:
Sartor Oliver,Silberstein Jonathan
Publisher
Springer Science and Business Media LLC
Reference7 articles.
1. Taylor, L. G., Canfield, S. E. & Du, X. L. Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer. Cancer 115, 2388–2399 (2009).
2. Cooperberg, M. R., Broering, J. M. & Carroll, P. R. Time trends and local variation in primary treatment of localized prostate cancer. J. Clin. Oncol. 28, 1117–1123 (2010).
3. Potosky, A. L. et al. Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer. J. Clin. Oncol.
http://dx.doi.org/JCO.2013.52.5782
.
4. Widmark, A. et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 373, 301–308 (2009).
5. Warde, P. et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet 378, 2104–2111 (2011).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献